The rash is gone but the pain remains: understanding postherpetic neuralgia
The shingles rash has healed, yet the skin still burns, shoots with pain, or hurts when clothing brushes against it. This does not mean the person is imagining the pain or that the virus must be active again. It may be postherpetic neuralgia (PHN): persistent nerve pain in the same area where the rash occurred.
The pain usually improves gradually, but it can sometimes last for months or longer. It is worth seeking assessment rather than simply enduring it. Treatment may not remove the pain immediately, but a well-adjusted plan can improve sleep, movement, and daily life.
How to recognise nerve pain after shingles
Postherpetic neuralgia develops in an area previously affected by varicella-zoster virus (VZV), the virus that causes chickenpox and shingles. According to the NHS, the pain may feel burning, aching, sharp, or shooting and may be constant or intermittent. Other typical features include itching, numbness, and allodynia—pain caused by a light touch, clothing pressure, or a change in temperature.
Symptoms most often begin during the rash or soon after it heals. Diagnosis is usually based on the character and location of pain in the same strip of skin. A blood antibody test cannot show whether VZV is causing the current pain. If the pattern is unusual, a clinician may look for other causes, including a bacterial skin infection, spinal disease, or another type of neuropathy.
How common is it, and who is at greater risk?
The CDC estimates that about 10% to 18% of people with shingles in the United States develop PHN. Risk rises substantially with age, and the complication is rare in people younger than 40. Severe pain at the start, a large or severe rash, a weakened immune system, and some other conditions, including diabetes, are also associated with greater risk.
These figures cannot predict one person’s course. Even severe pain may gradually ease, and duration varies widely—from a few months to more than a year.
When to seek medical help
Arrange an appointment if pain where the rash used to be is not improving or interferes with sleep, dressing, work, or movement. Earlier review is particularly important for older adults, pregnant people, people with weakened immunity, and those taking several medicines. The safest choice depends on kidney function, fall risk, heart disease, and possible drug interactions.
Seek urgent assessment if shingles or new symptoms involve the eye or nose; there is a red eye, light sensitivity, or a change in vision; or facial weakness, hearing changes, severe headache, confusion, a widespread rash, high fever, or a rapid decline develops. The NHS also advises urgent review for a rash near the eye, visual changes, or severe immunosuppression.
What a treatment plan may include
Ordinary painkillers help some people, but nerve pain often requires different medicines. A clinician may offer amitriptyline or duloxetine, gabapentin, or pregabalin. These medicines belong to different drug groups but are used for neuropathic pain. They are usually started at a low dose and adjusted gradually. Benefit may not appear immediately, while drowsiness, dizziness, and other adverse effects need monitoring.
A lidocaine plaster may be considered for localised pain. Short-term use of stronger pain relief is reserved for selected situations. Do not combine several sedating medicines, increase doses, or abruptly stop gabapentin, pregabalin, or an antidepressant without advice; agree any change with a clinician or pharmacist.
If pain is severe, substantially limits daily life, or does not respond to initial treatment, referral to a neurologist or pain clinic may help. Specialists can reassess the diagnosis, consider other options, and offer psychological approaches to chronic pain. These approaches do not deny the physical cause; they aim to reduce the effects of pain on sleep, anxiety, and activity.
Are antivirals needed after the rash has healed?
Aciclovir, valaciclovir, and famciclovir are used during acute shingles. The CDC says treatment is most effective within 72 hours: antivirals speed lesion resolution, reduce new lesions and viral shedding, and lessen acute pain.
However, antivirals are not pain treatment for established PHN. A Cochrane review of six randomised trials found that aciclovir did not reduce persistent pain at four or six months; evidence for other antivirals was insufficient. An important limitation is that its evidence search was last updated in 2013. This does not cancel the benefits of treating acute shingles early, but it explains why an antiviral should not be continued without advice as a remedy for nerve pain.
What may help at home
- Choose loose clothing made from soft cotton or silk to reduce friction.
- Try a cool pack wrapped in cloth; do not place ice directly on the skin.
- Keep a short diary of pain, sleep, activity, and adverse effects to help assess treatment.
- Return to usual activity gradually rather than waiting for every sensation to disappear, but stop if activity sharply worsens the pain.
If the skin has not yet healed, keep the rash clean and dry and avoid adhesive dressings. Until the blisters have crusted, VZV can pass to a person without immunity and cause chickenpox, not shingles.
Reducing future risk
The most reliable way to prevent PHN is to reduce the risk of shingles through vaccination. Policies differ by country. In the United States, the CDC recommends two doses of recombinant Shingrix vaccine for all adults aged 50 and older and for adults aged 19 and older with weakened immunity. A previous episode of shingles does not rule out vaccination, but the vaccine is not given during an active episode; discuss timing after recovery according to local guidance.
The key point: pain after the rash has healed is real and treatable, although finding an effective regimen may take time. Progress is measured not only by a pain score, but also by whether sleep, movement, and ordinary activities are returning.
Sources
- CDC: shingles symptoms and complications
- NHS: post-herpetic neuralgia
- CDC: clinical overview of shingles
- Cochrane: antivirals for preventing postherpetic neuralgia
- CDC: shingles vaccination
АС